Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Aug 10, 2022 11:55am
RE:Finished buying yesterday
Dead money, would have been better off investing in almost anything else. i am up just under 8% on HUT today and 6.5% on LSPD invested in bolth stocks end of day yesterday, because i knew the
...more
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Aug 09, 2022 10:11am
Finished buying yesterday
let's see if John F's this up .
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Aug 08, 2022 1:20pm
RE:Flipped
Predicable as always. Lol. Good job Czechcashings;)
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Aug 08, 2022 12:18pm
Flipped
3k @64, for 2 burgers if i can pick them back up under 61 i will. where is my friend davgro, i am expecting him to lash out soon. unless those in your head self help videos are working, in that case
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 07, 2022 9:43am
RE:RE:RE:RE:antiviral ...
It's hard to tell. It seems there's lots of science on-the-go right now. Don't have the details - just know they are busy. Updates are lagging and it seems for good reason - won't
...more
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Aug 06, 2022 9:56pm
RE:RE:RE:antiviral ...
Any time line for acute news?
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 06, 2022 3:55pm
RE:RE:antiviral ...
--------------------- Cash burn is an important concern and it must be managed well. But we are drug development and now more than ever, you want to spend to grow the funnel. Running P2 an growing
...more
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Aug 06, 2022 1:19pm
RE:antiviral ...
Your insights are always interesting. The problem is that when they burn the cash they received before the liver problem they are done since they won't get another penny and right now they have
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 06, 2022 9:24am
RE:antiviral ...
And like I said, I'm not a science guy so take these next comments loosely ... With the latest developments and understanding in Alzheimer's - where certain viruses (VZV) potentially could
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Aug 06, 2022 9:03am
antiviral ...
Interesting ... here is a study that shows a toe-to-toe comparison between Indomethacin and Naproxen, alone and in combination with Ketotifin (Asthma drug). You can see why Indomethacin was chosen by
...more
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Aug 05, 2022 11:05pm
RE:RE:RE:RE:AGM
Thanks for chiming in, stutters third handle lol.
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Aug 05, 2022 6:09pm
RE:RE:RE:RE:AGM
Projection with a smile
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 05, 2022 3:45pm
RE:RE:RE:AGM
Hahaha - if they didn't care so much, they'd be long gone. Not the case. Hanging around here because they're knee deep but don't have balls to tell. : )
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Aug 05, 2022 1:29pm
RE:RE:RE:AGM
Speak of brains loosing all your money to a pilot who runs a science company lmao!
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Aug 05, 2022 12:28pm
RE:RE:AGM
oh snap. Chichi is back lmao! Please make sure everyone go through his comments. Note his affinity to mugsy and his similarities to stutters for brains. He must've taken a page from
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >